×
Components:
Hypromellose
Method of action:
Emollient, Keratoprotective, Lubricating, Ophthalmologicals
Available in countries
See all
close
Medically reviewed by Kovalenko Svetlana Olegovna, PharmD. Last updated on 2019.12.07

Qualitative and quantitative composition

Hypromellose

Therapeutic indications

The information provided in Therapeutic indications of Lacrimel is based on data of another medicine with exactly the same composition as the Lacrimel of the medicine (Hypromellose). Be careful and be sure to specify the information on the section Therapeutic indications in the instructions to the drug Lacrimel directly from the package or from the pharmacist at the pharmacy.
more... close

This medicinal product acts as a lubricant and artificial tear in the symptomatic treatment of dehydration of the cornea and conjunctiva due to impaired lacrimal secretion and functional disorders as a result of topical or systemic diseases, or caused by deficient or incomplete eyelid closure. Artelac 3.2 mg/ml Eye Drops Solution is indicated in adults and children.

Dosage (Posology) and method of administration

The information provided in Dosage (Posology) and method of administration of Lacrimel is based on data of another medicine with exactly the same composition as the Lacrimel of the medicine (Hypromellose). Be careful and be sure to specify the information on the section Dosage (Posology) and method of administration in the instructions to the drug Lacrimel directly from the package or from the pharmacist at the pharmacy.
more... close

Posology

Suitable for use in adults and children. Unless otherwise directed, instil 1 drop into the conjunctival sac (corner of the eye, nearest the nose) 3 to 5 times per day or as required, to provide sufficient lubrication. Therapy of dry eye syndrome requires an individual dosage regimen.

Method of administration

For ocular use only.

Contraindications

The information provided in Contraindications of Lacrimel is based on data of another medicine with exactly the same composition as the Lacrimel of the medicine (Hypromellose). Be careful and be sure to specify the information on the section Contraindications in the instructions to the drug Lacrimel directly from the package or from the pharmacist at the pharmacy.
more... close

Hypersensitivity to the active substance (Lacrimel) or to any of the excipients.

Special warnings and precautions for use

The information provided in Special warnings and precautions for use of Lacrimel is based on data of another medicine with exactly the same composition as the Lacrimel of the medicine (Hypromellose). Be careful and be sure to specify the information on the section Special warnings and precautions for use in the instructions to the drug Lacrimel directly from the package or from the pharmacist at the pharmacy.
more... close

Stop treatment and consult a physician if irritation persists or worsens or new eye signs or symptoms develop. Wearers of soft contact lenses should remove their lenses before Artelac 3.2 mg/ml Eye Drops Solution is administered and should wait for at least 15 minutes before they insert them again. Ensure the dropper tip does not touch any surface including the eye surface.

Effects on ability to drive and use machines

The information provided in Effects on ability to drive and use machines of Lacrimel is based on data of another medicine with exactly the same composition as the Lacrimel of the medicine (Hypromellose). Be careful and be sure to specify the information on the section Effects on ability to drive and use machines in the instructions to the drug Lacrimel directly from the package or from the pharmacist at the pharmacy.
more... close

Artelac 3.2 mg/ml Eye Drops Solution on instillation may cause a short term blurring of vision when first used. If affected wait until vision has cleared before driving or operating machinery.

Undesirable effects

The information provided in Undesirable effects of Lacrimel is based on data of another medicine with exactly the same composition as the Lacrimel of the medicine (Hypromellose). Be careful and be sure to specify the information on the section Undesirable effects in the instructions to the drug Lacrimel directly from the package or from the pharmacist at the pharmacy.
more... close

The following adverse reactions have been reported following administration of Artelac 3.2 mg/ml Eye Drops Solution.

Eye disorder:

Very rare (<1/10,000):

Cases of corneal calcification have been reported very rarely in association with the use of phosphate containing eye drops in some patients with significantly damaged corneas.

Not known: Brief blurred vision or a slight stinging sensation on instilling Artelac 3.2 mg/ml Eye Drops Solution.

Reporting of suspected adverse reactions:

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via Yellow Card Scheme; Website: www.mhra.gov.uk/yellowcard.

Overdose

The information provided in Overdose of Lacrimel is based on data of another medicine with exactly the same composition as the Lacrimel of the medicine (Hypromellose). Be careful and be sure to specify the information on the section Overdose in the instructions to the drug Lacrimel directly from the package or from the pharmacist at the pharmacy.
more... close

No case of overdose has been reported.

Pharmacodynamic properties

The information provided in Pharmacodynamic properties of Lacrimel is based on data of another medicine with exactly the same composition as the Lacrimel of the medicine (Hypromellose). Be careful and be sure to specify the information on the section Pharmacodynamic properties in the instructions to the drug Lacrimel directly from the package or from the pharmacist at the pharmacy.
more... close

Pharmacotherapeutic group: Ophthalmologicals: other ophthalmologicals

ATC code: S01X A20

Lacrimel prolongs adhesion, enhances moistening of the cornea and conjunctiva and allows for a smoother movement of the conjunctiva over the cornea.

Pharmacokinetic properties

The information provided in Pharmacokinetic properties of Lacrimel is based on data of another medicine with exactly the same composition as the Lacrimel of the medicine (Hypromellose). Be careful and be sure to specify the information on the section Pharmacokinetic properties in the instructions to the drug Lacrimel directly from the package or from the pharmacist at the pharmacy.
more... close

Lacrimel does not permeate the cornea or reach the systemic circulation via the ophthalmic vessels.

Pharmacotherapeutic group

The information provided in Pharmacotherapeutic group of Lacrimel is based on data of another medicine with exactly the same composition as the Lacrimel of the medicine (Hypromellose). Be careful and be sure to specify the information on the section Pharmacotherapeutic group in the instructions to the drug Lacrimel directly from the package or from the pharmacist at the pharmacy.
more... close
Ophthalmologicals: other ophthalmologicals

Preclinical safety data

The information provided in Preclinical safety data of Lacrimel is based on data of another medicine with exactly the same composition as the Lacrimel of the medicine (Hypromellose). Be careful and be sure to specify the information on the section Preclinical safety data in the instructions to the drug Lacrimel directly from the package or from the pharmacist at the pharmacy.
more... close

Lacrimel has proved to be very well tolerated in local toxicity studies.

Incompatibilities

The information provided in Incompatibilities of Lacrimel is based on data of another medicine with exactly the same composition as the Lacrimel of the medicine (Hypromellose). Be careful and be sure to specify the information on the section Incompatibilities in the instructions to the drug Lacrimel directly from the package or from the pharmacist at the pharmacy.
more... close

Not applicable.

Special precautions for disposal and other handling

The information provided in Special precautions for disposal and other handling of Lacrimel is based on data of another medicine with exactly the same composition as the Lacrimel of the medicine (Hypromellose). Be careful and be sure to specify the information on the section Special precautions for disposal and other handling in the instructions to the drug Lacrimel directly from the package or from the pharmacist at the pharmacy.
more... close

Avoid contamination during use. Lacrimel SDU eye drops are sterile until first opened. For single use only. Each carton contains a patient insert with instructions for use.

Site feedback

How easy to use our site?

Commentary is required, without it we won't know how to become better
The maximum length of review is 1000 symbols

Thanks!

You help us to become better